Article Information
History
- February 16, 2022.
Article Versions
- Version 1 (November 19, 2021 - 12:49).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Laura A. Barrett, MS1,
- Aiwen Xing, MS2,
- Julia Sheffler, PhD3,
- Elizabeth Steidley1,
- Terrence J. Adam, RPh, MD, PhD4,
- Rui Zhang, PhD4 and
- Zhe He, PhD1,3,*
- 1School of Information, Florida State University, Tallahassee, FL, USA
- 2Department of Statistics, Florida State University, Tallahassee, FL, USA
- 3Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee, FL, USA
- 4Institute for Health Informatics and College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
- ↵*Corresponding Author:
Zhe He, PhD, School of Information, College of Communication and Information, Florida State University, 142 Collegiate Loop, Tallahassee, Florida 32306-2100, zhe{at}fsu.edu, Phone: 001(850)644-5775
Posted February 16, 2022.
Assessing the Use of Prescription Drugs in Obese Respondents in the National Health and Nutrition Examination Survey
